Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Avenir Wellness Solutions, Inc. (CURR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Exercised 117,647 shares
@ $0.265, valued at
$31.2k
Granted 117,647 options to buy
@ $0.7, valued at
$82.4k
|
|
| 08/21/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| BAGG GERALD (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Costantino Robert J (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 341,667 options to buy
@ $0.24, valued at
$82k
|
|
| 08/21/2023 |
4
| BAGG GERALD (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 13,491 options to buy
@ $0.12, valued at
$1.6k
|
|
| 08/21/2023 |
4
| Costantino Robert J (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 29,486 options to buy
@ $0.12, valued at
$3.5k
|
|
| 08/21/2023 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 13,491 options to buy
@ $0.12, valued at
$1.6k
|
|
| 09/15/2022 |
4
| BAGG GERALD (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 220,795 shares
@ $0 |
|
| 09/13/2022 |
4
| Costantino Robert J (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 226,764 shares
@ $0 |
|
| 09/13/2022 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 220,795 shares
@ $0 |
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Berlent Jonathan (Chief Business Officer) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Bought 10,000 shares
@ $0.69, valued at
$6.9k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| KING-SHAW RUBEN JR (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 100,000 options
@ $3.4, valued at
$340k
Granted 61,654 restricted stock units
@ $0 |
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Chung Lauren (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 21,579 shares
@ $0
Granted 61,654 restricted stock units
@ $0 |
|
| 05/27/2021 |
4
| Held Joshua (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 2,106,315 shares
@ $0
Granted 100,000 options
@ $4.01, valued at
$401k
Granted 61,654 restricted stock units
@ $0 |
|
| 05/27/2021 |
4
| Berlent Jonathan (Chief Business Officer) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 62,500 options
@ $1.2, valued at
$75k
Granted 187,500 options
@ $1.2, valued at
$225k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 250,000 shares
@ $0
Granted 1,621,877 shares
@ $0
Granted 50,000 shares
@ $0
Granted 100,000 shares
@ $0
Granted 100,000 options
@ $3.4, valued at
$340k
Granted 61,654 restricted stock units
@ $0 |
|
| 05/27/2021 |
4
| Goldin Anna (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 21,579 shares
@ $0
Granted 61,654 restricted stock units
@ $0 |
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| Davidson Robert Steven (CEO) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Bought 2,300 shares
@ $1.42, valued at
$3.3k
Bought 2,415 shares
@ $1.45, valued at
$3.5k
Bought 2,172 shares
@ $1.44, valued at
$3.1k
|
|
| 06/04/2019 |
4
| Redard Michael (CFO) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 200,000 options
@ $4.01, valued at
$802k
Granted 50,000 options
@ $4.01, valued at
$200.5k
|
|
| 04/17/2019 |
4
| Climate Change Investigation, Innovation & Investment Company, LLC (10% Owner) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Sold 500 shares
@ $3.88, valued at
$1.9k
Sold 2,500 shares
@ $3.89, valued at
$9.7k
Sold 3,372 shares
@ $3.82, valued at
$12.9k
Sold 800 shares
@ $3.83, valued at
$3.1k
Sold 828 shares
@ $3.84, valued at
$3.2k
Sold 900 shares
@ $3.9, valued at
$3.5k
Sold 4,500 shares
@ $3.89, valued at
$17.5k
Sold 1,383 shares
@ $3.78, valued at
$5.2k
Sold 200 shares
@ $3.8, valued at
$760
Sold 1,100 shares
@ $3.78, valued at
$4.2k
Sold 7,292 shares
@ $3.6, valued at
$26.3k
|
|
| 04/17/2019 |
4
| Climate Change Investigation, Innovation & Investment Company, LLC (10% Owner) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Sold 12,680 shares
@ $2.03, valued at
$25.7k
Sold 5,000 shares
@ $2.0162, valued at
$10.1k
Sold 3,000 shares
@ $2.01, valued at
$6k
Sold 1,695 shares
@ $2.035, valued at
$3.4k
Sold 4,800 shares
@ $2.04, valued at
$9.8k
Sold 7,000 shares
@ $2.03, valued at
$14.2k
Sold 12,000 shares
@ $2.404, valued at
$28.8k
Sold 5,100 shares
@ $2.4, valued at
$12.2k
Sold 7,900 shares
@ $2.432, valued at
$19.2k
Sold 15,264 shares
@ $3.41, valued at
$52.1k
Sold 3,250 shares
@ $3.4, valued at
$11.1k
|
|
| 01/28/2019 |
4
| Climate Change Investigation, Innovation & Investment Company, LLC (10% Owner) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Exercised 5,000 shares
@ $2, valued at
$10k
Exercised 1,100 shares
@ $2, valued at
$2.2k
Exercised 100 shares
@ $2.05, valued at
$205
Exercised 2,300 shares
@ $2, valued at
$4.6k
|
|
| 12/17/2018 |
4
| Climate Change Investigation, Innovation & Investment Company, LLC (10% Owner) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Exercised 297,288 shares
@ $0.886, valued at
$263.4k
Bought 50,000 warrants
@ $250000, valued at
$12500M
Bought 148,644 warrants
@ $250000, valued at
$37161M
|
|
|
|